Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Regulatory News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 248.00
Bid: 247.50
Ask: 248.00
Change: 2.50 (1.02%)
Spread: 0.50 (0.202%)
Open: 247.00
High: 248.00
Low: 247.00
Prev. Close: 245.50
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Next steps on NHS response to COVID-19

18 Mar 2020 07:00

RNS Number : 5393G
Spire Healthcare Group PLC
18 March 2020
 

Spire Healthcare Group plc

 

("Spire Healthcare", "the Company" or "the Group")

 

Next steps on NHS response to COVID-19

 

18 March 2020

 

Further to its RNS published on Friday 13 March, Spire Healthcare (LSE: SPI), a leading UK independent hospital group, can today provide a further update on the cooperation between the NHS and the independent healthcare sector.

 

Sir Simon Stevens, NHS Chief Executive, has written to the CEOs of all NHS trusts, foundation trusts, CCGs, GPs and providers of community health services clarifying arrangements between the NHS and independent sector and Spire Healthcare welcomes this development.

 

For clarity, in his letter, Sir Simon Stevens says:

 

NHS trusts should "postpone all non-urgent elective operations from 15th April at the latest, for a period of at least three months. However, you also have full local discretion to wind down elective activity over the next 30 days as you see best."

 

"In the interim, providers should continue to use all available capacity for elective operations including the independent sector, before COVID constraints curtail such work."

 

and continues to say:

 

"Nationally we are now in the process of block-buying capacity in independent hospitals. This should be completed within a fortnight. Their staff and facilities will then be flexibly available to you for urgent surgery, as well as for repurposing their beds, operating theatres and recovery facilities to provide respiratory support for COVID-19 patients."

 

Spire Healthcare confirms that it continues to provide both planned NHS and private care in its hospitals until the point when focus switches to supporting the Government's efforts in combatting this disease. Spire Healthcare remains fully committed to using the resources at its disposal to help the NHS.

 

We will update the market when further information is available

 

For further information please contact:

 

Spire Healthcare

Cora McCallum, Head of Investor Relations

 

+44 (0)20 7427 9169

Instinctif Partners

Damian ReeceGuy Scarborough

+44 (0)20 7457 2020

Registered Office and Head Office:

 

Spire Healthcare Group plc3 Dorset RiseLondonEC4Y 8EN

Registered number 09084066

 

 

About Spire Healthcare

 

Spire Healthcare is a leading independent hospital group in the United Kingdom, with 39 private hospitals and 8 clinics across England, Wales and Scotland.

 

Working in partnership with around 7,300 experienced consultants, Spire Healthcare delivered tailored, personalised care to approximately 810,000 in-patients and daycase patients in 2019, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom.

 

The Group's well located and scalable hospitals have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, consultants, the NHS, GPs and Private Medical Insurance ("PMI") providers. 85% of Spire Healthcare's hospitals are rated Good or Outstanding by the CQC (or the equivalent in Scotland and Wales).

 

Spire treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FUREAFDXFLKEEAA
Date   Source Headline
14th Oct 202210:00 amRNSChanges to Board of Directors and committees
3rd Oct 20224:04 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSBlock Listing Six Monthly Return
8th Sep 20227:00 amRNSInterim Results
1st Sep 20229:51 amRNSTotal Voting Rights
23rd Aug 20222:55 pmRNSHolding(s) in Company
15th Aug 20227:00 amRNSNotice of Interim Results
4th Aug 20222:11 pmRNSHolding(s) in Company
1st Aug 20222:43 pmRNSTotal Voting Rights
19th Jul 20229:07 amRNSBlock listing Interim Review
14th Jul 20223:48 pmRNSHolding(s) in Company
13th Jul 20224:43 pmRNSHolding(s) in Company
6th Jul 20224:00 pmRNSDirector/PDMR Shareholding
1st Jul 202210:28 amRNSTotal Voting Rights
29th Jun 20223:56 pmRNSHolding(s) in Company
29th Jun 20227:00 amRNSCapital Markets Event and new agreement with BUPA
1st Jun 20227:54 amRNSTotal Voting Rights
19th May 20227:44 amRNSHolding(s) in Company
18th May 20223:15 pmRNSHolding(s) in Company
13th May 202210:43 amRNSDirector/PDMR Shareholding
11th May 20224:25 pmRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
6th May 20227:00 amRNSNotice of Capital Markets Day
3rd May 20228:46 amRNSTotal Voting Rights
27th Apr 20223:49 pmRNSDirector/PDMR Shareholding
6th Apr 20229:55 amRNSDirector/PDMR Shareholding
1st Apr 20224:40 pmRNS2021 Annual Report and 2022 Notice of AGM
1st Apr 202212:32 pmRNSHolding(s) in Company
1st Apr 202211:10 amRNSTotal Voting Rights
25th Mar 20222:51 pmRNSBlock listing application
24th Mar 20225:16 pmRNSHolding(s) in Company
16th Mar 20228:07 amRNSDirector/PDMR Shareholding
9th Mar 20227:43 amRNSHolding(s) in Company
4th Mar 20226:12 pmRNSHolding(s) in Company
4th Mar 20223:14 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
1st Mar 20227:23 amRNSTotal Voting Rights
25th Feb 202212:21 pmRNSHolding(s) in Company
25th Feb 20227:00 amRNSRe-financing of funding facilities
22nd Feb 20223:26 pmRNSHolding(s) in Company
22nd Feb 20221:38 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSManagement update
8th Feb 20227:00 amRNSNotice of Preliminary Results
1st Feb 20229:29 amRNSTotal Voting Rights
27th Jan 20222:57 pmRNSTotal Voting Rights
18th Jan 20227:00 amRNSUpdate on shareholder views
13th Jan 20224:52 pmRNSHolding(s) in Company
12th Jan 20222:40 pmRNSHolding(s) in Company
12th Jan 20222:38 pmRNSHolding(s) in Company
11th Jan 202210:14 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.